About ORBIT GENOMICS, INC.
Orbit Genomics is a company focused on precision medicine, developing AI-enabled genomic technologies for early diagnosis of complex diseases, with a lead product, OrbiSeq-L, a non-invasive blood test for early-stage lung cancer.
AI-enabled genomic analysis of repetitive DNA (short tandem repeats)Non-invasive diagnostic testing for early-stage lung cancerDevelopment of clinically actionable products for precision medicineScalable genomics platform for disease diagnosis, risk stratification, and precision intervention
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to ORBIT GENOMICS, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.